Exponent, Inc. (NASDAQ:EXPO) Shares Bought by Saturna Capital Corp

Saturna Capital Corp raised its position in Exponent, Inc. (NASDAQ:EXPO) by 5.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 7,394 shares of the business services provider’s stock after acquiring an additional 394 shares during the period. Saturna Capital Corp’s holdings in Exponent were worth $852,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of EXPO. Quarry LP acquired a new stake in Exponent in the second quarter valued at approximately $25,000. GAMMA Investing LLC lifted its stake in shares of Exponent by 67.7% during the second quarter. GAMMA Investing LLC now owns 379 shares of the business services provider’s stock worth $36,000 after buying an additional 153 shares during the period. Whittier Trust Co. of Nevada Inc. lifted its stake in shares of Exponent by 166.5% during the second quarter. Whittier Trust Co. of Nevada Inc. now owns 517 shares of the business services provider’s stock worth $49,000 after buying an additional 323 shares during the period. USA Financial Formulas acquired a new stake in shares of Exponent during the third quarter worth $60,000. Finally, Benjamin F. Edwards & Company Inc. lifted its stake in shares of Exponent by 70.5% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 873 shares of the business services provider’s stock worth $83,000 after buying an additional 361 shares during the period. 92.37% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Exponent

In related news, Director Paul R. Johnston sold 14,000 shares of the business’s stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $104.60, for a total transaction of $1,464,400.00. Following the completion of the transaction, the director now directly owns 80,742 shares in the company, valued at $8,445,613.20. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In related news, Director Carol Lindstrom sold 1,039 shares of the business’s stock in a transaction on Monday, November 4th. The shares were sold at an average price of $96.32, for a total transaction of $100,076.48. Following the completion of the transaction, the director now directly owns 5,871 shares in the company, valued at $565,494.72. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Paul R. Johnston sold 14,000 shares of the business’s stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $104.60, for a total transaction of $1,464,400.00. Following the transaction, the director now owns 80,742 shares of the company’s stock, valued at $8,445,613.20. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.10% of the stock is currently owned by insiders.

Exponent Trading Up 0.8 %

NASDAQ:EXPO opened at $103.77 on Wednesday. Exponent, Inc. has a 12 month low of $68.70 and a 12 month high of $115.75. The firm has a fifty day simple moving average of $107.54 and a 200-day simple moving average of $101.96. The company has a market capitalization of $5.27 billion, a P/E ratio of 49.75 and a beta of 0.69.

Exponent Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 20th. Stockholders of record on Friday, December 6th will be paid a dividend of $0.28 per share. The ex-dividend date of this dividend is Friday, December 6th. This represents a $1.12 annualized dividend and a dividend yield of 1.08%. Exponent’s payout ratio is currently 54.11%.

Wall Street Analyst Weigh In

Separately, Truist Financial reiterated a “buy” rating and set a $120.00 price objective (up from $100.00) on shares of Exponent in a research note on Friday, July 26th.

Exponent Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.